Tienocarbine

This classification denotes an antipsychotic agent with the molecular formula C15H16N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B255B0J51N, chemically known as 7,8,9,10-tetrahydro-1,9-dimethyl-6h-pyrido(4,3-b)thieno(3,2-e)indole but generally known as tienocarbine, which bears US NIH Compound Identifier 71140. European Medicines Agency schedules Tienocarbine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11033MIG. The term TIENOCARBINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 1, 2000, List 43). TIENOCARBINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tienocarbine under HS 29349990 and SITC 51579. As of Q4 2014, TIENOCARBINE remains the US FDA Preferred Term for this commodity. Tienocarbine bears US NLM identifiers UMLS ID C0076666 and NCI Concept Code C76449. SMILES: S1C2C(C3C4C([NH]C3CC2)CCN(C4)C)C(C1)C.